Official account of the @uiowa Cerebrovascular & Neurointerventional Research Lab at @uihealthcare. Director: Dr. Ortega-Gutierrez
Iowa City, IA
Joined October 2020
- Tweets1.5K
- Following374
- Followers3.4K
- Likes1.7K
Cerebrovascular & Neurointerventional Lab retweeted
Join us at the #SVIN26 20th Anniversary Gala! Comedian T.J. Miller is taking the stage with a custom performance and hosting our annual awards presentation.
Cocktails, comedy, and two decades of milestones — Thursday, November 19 at Zouk Nightclub: zurl.co/miZaD
#StrokeAwareness #SVINAnnualMeeting #GoAllIn
Flow models, case reviews and neurointervention fellows at the Stryker Learning Center, Salt Lake City. Dr. Ortega (Cerebrovascular and Neurointerventional Lab, University of Iowa) served as faculty at the 35th SKILL NeuroElite Fall Fellows Course, Sep 30 to Oct 2, 2026.
Six domains, one thread. Some of what we work on at the Cerebrovascular and Neurointerventional Lab, University of Iowa, and what each is for.
Mechanical thrombectomy - a minimally invasive procedure for acute ischemic stroke.
The Cerebrovascular and Neurointerventional Lab at the University of Iowa. #Neurointervention #Stroke #Cerebrovascular
Congrats Giuseppe …. Now you really have the dream team there!!
Special day for the Mayo Clinic Neurovascular Unit. Marc Ribo from Barcelona has joined our great Team!!!!@MayoClinicNeuro
"Access to life-saving treatment should not be determined by where a patient lives."
Santiago Ortega-Gutiérrez, our director, as President of SVIN. Mission Thrombectomy convened with BCIU, Philips and @Medtronic_NV @Medtronic.
Full news from @svinsociety:
prnewswire.com/news-releases…
In Mexico City, Dr. Vanessa Cano, Dr. Andrés Mercado and Dr. Araus enrolled their institution's second patient in DONE SYMPLE - the 10th subject worldwide.
Five of 18 sites across 11 countries are now active. Cerebrovascular and Neurointerventional Lab, University of Iowa, DONE SYMPLE October 2026 newsletter.
#stroke #clinicaltrials
Instituto Nacional de Neurología in Mexico City has enrolled its 10th patient in DONE SYMPLE - late-window ischemic stroke selection by automatic plain CT.
Enrolment there is led by Dra Vanessa Cano. Cerebrovascular and Neurointerventional Laboratory, University of Iowa, leads the trial.
#stroke #thrombectomy
clinicaltrials.gov/study/NCT…
Cerebrovascular & Neurointerventional Lab retweeted
New at #SVIN26: the Delineating the Diagnosis: ILR Implantation Workshop pairs evidence review with hands-on simulation so you can walk away with real, practiced skills in implantable loop recorder procedures for AFib detection.
Sign up when you register for the Annual Meeting at: hhttps://www.svin.org/i4a/pages/index.cfm?pageid=3802
#StrokeAwareness #SVIN #SVINAnnualMeeting #GoAllIn
Running a stroke trial across 20 sites is mostly not about the stroke. It's whether a site activates in weeks not months. Whether imaging arrives in a form a core lab can adjudicate. Whether the data reaching the statistician is the data that happened at the bedside.
#ClinicalTrials #ClinicalResearch #DataManagement
In a new meta-analysis from this lab, LVO prevalence was 29.3% among EMS-transported patients against 23.1% pooled - and ranged from 11.2% to 40% between studies. Which population you triage changes the number.
@AndersonBr17 & MAP-STROKE team: Stroke Vasc Interv Neurol. 2026;6:e002576. doi.org/10.1161/SVIN.126.002…
In CVT, acute blood biomarkers seem to be associated with 6-month functional recovery. Strong work by the CLOT-VENUS registry (US & Mexico). Stroke has just highlighted our paper on Blogging Stroke. Four ratios, four thresholds, the same pattern - worth reading in full.
doi.org/10.1161/STROKEAHA.12…
Cruz-Criollo L, et al (...) Ortega-Gutierrez, S. Stroke. 2026;57:1632-1642.
Cerebrovascular & Neurointerventional Lab retweeted
Article Commentary: “Early Inflammatory Biomarkers Associated With Functional Outcomes in Acute Cerebral Venous Thrombosis”
In this #BloggingStroke post, Natalie Neale discusses #Stroke article by @LeonardoCruz_C et al. ahajournals.org/do/10.1161/b…
Median share of eligible stroke patients who receive thrombectomy worldwide: 2.79%. There was a 460-fold disparity between the highest and lowest income countries. Low-income countries had 88% lower access. Global MT operator availability was set at 16.5%.
Kaiz S. Asif, MD, (...) Santiago Ortega-Gutierrez, MD, MSc, and Dileep R. Yavagal, on behalf of the Global Executive Committee of the MT-GLASS Study. MT-GLASS, Circulation 2023;147(16).
#Stroke #Thrombectomy #GlobalHealth
